Home » Pharma & Healthcare » Global Rheumatoid Arthritis Drugs Market by Player, Region, Type, Application and Sales Channel, Forecast 2021-2030

Global Rheumatoid Arthritis Drugs Market by Player, Region, Type, Application and Sales Channel, Forecast 2021-2030

  118 Pages     Pharma & Healthcare  

Available Formats      

Report ID: 81894
Published By: MAResearch

Summary

The Global Rheumatoid Arthritis Drugs Market was valued at $XX million in 2020, and research analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030.

This report studies the Rheumatoid Arthritis Drugs market, covering market size for segment by type (Rx Drugs, OTC Drugs, etc.), by application (Hospital Pharmacy, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Rheumatoid Arthritis Drugs from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Rheumatoid Arthritis Drugs market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Rheumatoid Arthritis Drugs including:

  • Takeda Pharmaceutical
  • Sanofi
  • Genentech
  • Novartis
  • Janssen Biotech
  • Amgen
  • AbbVie
  • Pfizer
  • Bristol-Myers Squibb
  • Merck
  • UCB Biosciences
  • Mitsubishi Tanabe Pharma
  • Biogen Inc

Market split by Type, can be divided into:

  • Rx Drugs
  • OTC Drugs

Market split by Application, can be divided into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Market split by Sales Channel, can be divided into:

  • Direct Channel
  • Distribution Channel

Market segment by Region/Country including:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

Chapter 1 Rheumatoid Arthritis Drugs Market Overview

1.1 Rheumatoid Arthritis Drugs Definition

1.2 Global Rheumatoid Arthritis Drugs Market Size Status and Outlook (2015-2030)

1.3 Global Rheumatoid Arthritis Drugs Market Size Comparison by Region (2015-2030)

1.4 Global Rheumatoid Arthritis Drugs Market Size Comparison by Type (2015-2030)

1.5 Global Rheumatoid Arthritis Drugs Market Size Comparison by Application (2015-2030)

1.6 Global Rheumatoid Arthritis Drugs Market Size Comparison by Sales Channel (2015-2030)

1.7 Rheumatoid Arthritis Drugs Market Dynamics (COVID-19 Impacts)

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Mergers/Acquisitions/Expansion)

1.7.4 COVID-19 Impacts on Current Market

1.7.5 Post-Strategies of COVID-19 Outbreak

Chapter 2 Rheumatoid Arthritis Drugs Market Segment Analysis by Player

2.1 Global Rheumatoid Arthritis Drugs Sales and Market Share by Player (2018-2020)

2.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Player (2018-2020)

2.3 Global Rheumatoid Arthritis Drugs Average Price by Player (2018-2020)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Segment by Player

Chapter 3 Rheumatoid Arthritis Drugs Market Segment Analysis by Type

3.1 Global Rheumatoid Arthritis Drugs Market by Type

3.1.1 Rx Drugs

3.1.2 OTC Drugs

3.2 Global Rheumatoid Arthritis Drugs Sales and Market Share by Type (2015-2020)

3.3 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Type (2015-2020)

3.4 Global Rheumatoid Arthritis Drugs Average Price by Type (2015-2020)

3.5 Leading Players of Rheumatoid Arthritis Drugs by Type in 2020

3.6 Conclusion of Segment by Type

Chapter 4 Rheumatoid Arthritis Drugs Market Segment Analysis by Application

4.1 Global Rheumatoid Arthritis Drugs Market by Application

4.1.1 Hospital Pharmacy

4.1.2 Retail Pharmacy

4.1.3 Online Pharmacy

4.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Application (2015-2020)

4.3 Leading Consumers of Rheumatoid Arthritis Drugs by Application in 2020

4.4 Conclusion of Segment by Application

Chapter 5 Rheumatoid Arthritis Drugs Market Segment Analysis by Sales Channel

5.1 Global Rheumatoid Arthritis Drugs Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Sales Channel (2015-2020)

5.3 Leading Distributors/Dealers of Rheumatoid Arthritis Drugs by Sales Channel in 2020

5.4 Conclusion of Segment by Sales Channel

Chapter 6 Rheumatoid Arthritis Drugs Market Segment Analysis by Region

6.1 Global Rheumatoid Arthritis Drugs Market Size and CAGR by Region (2015-2030)

6.2 Global Rheumatoid Arthritis Drugs Sales and Market Share by Region (2015-2020)

6.3 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Region (2015-2020)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America Rheumatoid Arthritis Drugs Market Share by Type

6.4.3 North America Rheumatoid Arthritis Drugs Market Share by Application

6.4.4 United States

6.4.5 Canada

6.4.6 Mexico

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe Rheumatoid Arthritis Drugs Market Share by Type

6.5.3 Europe Rheumatoid Arthritis Drugs Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Russia

6.5.9 Spain

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific Rheumatoid Arthritis Drugs Market Share by Type

6.6.3 Asia-Pacific Rheumatoid Arthritis Drugs Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America Rheumatoid Arthritis Drugs Market Share by Type

6.7.3 South America Rheumatoid Arthritis Drugs Market Share by Application

6.7.4 Brazil

6.7.5 Argentina

6.7.6 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa Rheumatoid Arthritis Drugs Market Share by Type

6.8.3 Middle East & Africa Rheumatoid Arthritis Drugs Market Share by Application

6.8.4 UAE

6.8.5 Saudi Arabia

6.8.6 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Rheumatoid Arthritis Drugs Players

7.1 Takeda Pharmaceutical

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.1.4 COVID-19 Impact on Takeda Pharmaceutical

7.2 Sanofi

7.3 Genentech

7.4 Novartis

7.5 Janssen Biotech

7.6 Amgen

7.7 AbbVie

7.8 Pfizer

7.9 Bristol-Myers Squibb

7.10 Merck

7.11 UCB Biosciences

7.12 Mitsubishi Tanabe Pharma

7.13 Biogen Inc

Chapter 8 Upstream and Downstream Analysis of Rheumatoid Arthritis Drugs

8.1 Industrial Chain of Rheumatoid Arthritis Drugs

8.2 Upstream of Rheumatoid Arthritis Drugs

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.2.4 Manufacturing Cost Structure

8.2.5 Manufacturing Process

8.3 Downstream of Rheumatoid Arthritis Drugs

8.3.1 Leading Distributors/Dealers of Rheumatoid Arthritis Drugs

8.3.2 Leading Consumers of Rheumatoid Arthritis Drugs

Chapter 9 Development Trend of Rheumatoid Arthritis Drugs (2021-2030)

9.1 Global Rheumatoid Arthritis Drugs Market Size (Sales and Revenue) Forecast (2021-2030)

9.2 Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Region (2021-2030)

9.3 Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Type (2021-2030)

9.4 Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Application (2021-2030)

9.5 Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Sales Channel (2021-2030)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

Figure Rheumatoid Arthritis Drugs Example

Figure Global Rheumatoid Arthritis Drugs Revenue (Million $) Status and Outlook (2015-2030)

Figure Global Rheumatoid Arthritis Drugs Revenue (Million $) Comparison by Region (2015-2030)

Figure Global Rheumatoid Arthritis Drugs Revenue (Million $) Comparison by Type (2015-2030)

Figure Global Rheumatoid Arthritis Drugs Revenue (Million $) Comparison by Application (2015-2030)

Figure Global Rheumatoid Arthritis Drugs Revenue (Million $) Comparison by Sales Channel (2015-2030)

Table Global Rheumatoid Arthritis Drugs Sales by Player (2018-2020)

Table Global Rheumatoid Arthritis Drugs Sales Market Share by Player (2018-2020)

Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Player in 2020

Table Global Rheumatoid Arthritis Drugs Revenue (Million $) by Player (2018-2020)

Table Global Rheumatoid Arthritis Drugs Revenue Market Share by Player (2018-2020)

Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Player in 2020

Table Global Rheumatoid Arthritis Drugs Average Price by Player (2018-2020)

Figure Global Rheumatoid Arthritis Drugs Average Price by Player in 2020

Figure Global Rheumatoid Arthritis Drugs Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018

Figure Global Rheumatoid Arthritis Drugs Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020

Figure Example of Rx Drugs

Figure Global Rx Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of OTC Drugs

Figure Global OTC Drugs Revenue (Million $) and Growth Rate (2015-2020)

Table Global Rheumatoid Arthritis Drugs Sales by Type (2015-2020)

Table Global Rheumatoid Arthritis Drugs Sales Market Share by Type (2015-2020)

Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Type in 2020

Table Global Rheumatoid Arthritis Drugs Revenue (Million $) by Type (2015-2020)

Table Global Rheumatoid Arthritis Drugs Revenue Market Share by Type (2015-2020)

Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Type in 2020

Table Global Rheumatoid Arthritis Drugs Average Price by Type (2015-2020)

Figure Global Rheumatoid Arthritis Drugs Average Price by Type in 2020

Table Leading Players of Rheumatoid Arthritis Drugs by Type in 2020

Figure Example of Hospital Pharmacy

Figure Global Rheumatoid Arthritis Drugs for Hospital Pharmacy Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Retail Pharmacy

Figure Global Rheumatoid Arthritis Drugs for Retail Pharmacy Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Online Pharmacy

Figure Global Rheumatoid Arthritis Drugs for Online Pharmacy Revenue (Million $) and Growth Rate (2015-2020)

Table Global Rheumatoid Arthritis Drugs Sales by Application (2015-2020)

Table Global Rheumatoid Arthritis Drugs Sales Market Share by Application (2015-2020)

Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Application in 2020

Table Leading Consumers of Rheumatoid Arthritis Drugs by Application in 2020

Figure Example of Direct Channel

Figure Global Rheumatoid Arthritis Drugs for Direct Channel Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Distribution Channel

Figure Global Rheumatoid Arthritis Drugs for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020)

Table Global Rheumatoid Arthritis Drugs Revenue by Sales Channel (2015-2020)

Table Global Rheumatoid Arthritis Drugs Revenue Market Share by Sales Channel (2015-2020)

Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Sales Channel in 2020

Table Leading Distributors/Dealers of Rheumatoid Arthritis Drugs by Sales Channel in 2020

Table Global Rheumatoid Arthritis Drugs Market Size and CAGR by Region (2015-2030)

Table Global Rheumatoid Arthritis Drugs Sales by Region (2015-2020)

Table Global Rheumatoid Arthritis Drugs Sales Market Share by Region (2015-2020)

Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Region in 2020

Table Global Rheumatoid Arthritis Drugs Revenue (Million $) by Region (2015-2020)

Table Global Rheumatoid Arthritis Drugs Revenue Market Share by Region (2015-2020)

Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Region in 2020

Table North America Rheumatoid Arthritis Drugs Sales by Country (2015-2020)

Figure North America Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)

Table North America Rheumatoid Arthritis Drugs Revenue by Country (2015-2020)

Figure North America Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)

Figure North America Rheumatoid Arthritis Drugs Market Share by Type in 2020

Figure North America Rheumatoid Arthritis Drugs Market Share by Application in 2020

Figure United States Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure United States Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Canada Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Canada Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Mexico Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Mexico Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Table Europe Rheumatoid Arthritis Drugs Sales by Country (2015-2020)

Figure Europe Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)

Table Europe Rheumatoid Arthritis Drugs Revenue by Country (2015-2020)

Figure Europe Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)

Figure Europe Rheumatoid Arthritis Drugs Market Share by Type in 2020

Figure Europe Rheumatoid Arthritis Drugs Market Share by Application in 2020

Figure Germany Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Germany Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure UK Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure UK Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure France Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure France Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Italy Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Italy Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Russia Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Russia Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Spain Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Spain Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Table Asia-Pacific Rheumatoid Arthritis Drugs Sales by Country (2015-2020)

Figure Asia-Pacific Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)

Table Asia-Pacific Rheumatoid Arthritis Drugs Revenue by Country (2015-2020)

Figure Asia-Pacific Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)

Figure Asia-Pacific Rheumatoid Arthritis Drugs Market Share by Type in 2020

Figure Asia-Pacific Rheumatoid Arthritis Drugs Market Share by Application in 2020

Figure China Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure China Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Japan Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Japan Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Korea Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Korea Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure India Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure India Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Southeast Asia Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Southeast Asia Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Australia Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Australia Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Table South America Rheumatoid Arthritis Drugs Sales by Country (2015-2020)

Figure South America Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)

Table South America Rheumatoid Arthritis Drugs Revenue by Country (2015-2020)

Figure South America Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)

Figure South America Rheumatoid Arthritis Drugs Market Share by Type in 2020

Figure South America Rheumatoid Arthritis Drugs Market Share by Application in 2020

Figure Brazil Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Brazil Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Argentina Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Argentina Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Colombia Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Colombia Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Table Middle East & Africa Rheumatoid Arthritis Drugs Sales by Country (2015-2020)

Figure Middle East & Africa Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)

Table Middle East & Africa Rheumatoid Arthritis Drugs Revenue by Country (2015-2020)

Figure Middle East & Africa Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)

Figure Middle East & Africa Rheumatoid Arthritis Drugs Market Share by Type in 2020

Figure Middle East & Africa Rheumatoid Arthritis Drugs Market Share by Application in 2020

Figure UAE Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure UAE Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure Saudi Arabia Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure Saudi Arabia Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Figure South Africa Rheumatoid Arthritis Drugs Sales and Growth Rate (2015-2020)

Figure South Africa Rheumatoid Arthritis Drugs Revenue (Million $) and Growth Rate (2015-2020)

Table Company Snapshot of Takeda Pharmaceutical

Table Rheumatoid Arthritis Drugs Introduction of Takeda Pharmaceutical

Table Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share of Takeda Pharmaceutical (2018-2020)

Table Industrial Chain of Rheumatoid Arthritis Drugs

Table Manufacturing Cost Structure of Rheumatoid Arthritis Drugs

Table General Manufacturing Process of Rheumatoid Arthritis Drugs

Table Leading Distributors/Dealers of Rheumatoid Arthritis Drugs

Table Leading Consumers of Rheumatoid Arthritis Drugs

Figure Global Rheumatoid Arthritis Drugs Sales and Growth Rate Forecast (2021-2030)

Figure Global Rheumatoid Arthritis Drugs Revenue and Growth Rate Forecast (2021-2030)

Table Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Region (2021-2030)

Table Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Type (2021-2030)

Table Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Application (2021-2030)

Table Global Rheumatoid Arthritis Drugs Market Size and CAGR Forecast by Sales Channel (2021-2030)

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020